These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3976935)

  • 1. Possible dexamethasone influences on subsequent serial DST results.
    Rihmer Z; Arató M; Greden JF
    Am J Psychiatry; 1985 Apr; 142(4):519-20. PubMed ID: 3976935
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin reuptake inhibitors and DST status.
    Holsboer F; Von Bardeleben U
    Am J Psychiatry; 1987 Feb; 144(2):263-4. PubMed ID: 3492933
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ
    Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory disturbances and dexamethasone suppression test in major depression.
    Wauthy J; Ansseau M; von Frenckell R; Mormont C; Legros JJ
    Biol Psychiatry; 1991 Oct; 30(7):736-8. PubMed ID: 1958771
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J; Linka M; Matkowski K; Kanarkowski R
    Psychiatr Pol; 1991; 25(5):9-15. PubMed ID: 1821997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination between patients with melancholic depression and healthy controls: comparison between 24-h cortisol profiles, the DST and the Dex/CRH test.
    Paslakis G; Krumm B; Gilles M; Schweiger U; Heuser I; Richter I; Deuschle M
    Psychoneuroendocrinology; 2011 Jun; 36(5):691-8. PubMed ID: 21035272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REM latency and DST results.
    Mendlewicz J
    Am J Psychiatry; 1984 Mar; 141(3):473-4. PubMed ID: 6703125
    [No Abstract]   [Full Text] [Related]  

  • 8. The dexamethasone suppression test.
    Harris E
    Am J Nurs; 1982 May; 82(5):784-5. PubMed ID: 6918185
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal axis in schizophrenia.
    Altamura AC
    Biol Psychiatry; 1996 Sep; 40(6):560-1. PubMed ID: 8879482
    [No Abstract]   [Full Text] [Related]  

  • 10. DST in depression is unaffected by altering the clock time of its administration.
    Pepper GM; Davis KL; Davis BM; Krieger DT
    Psychiatry Res; 1983 Feb; 8(2):105-9. PubMed ID: 6574528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone response to clonidine and the cortisol response to dexamethasone in depressive patients.
    Valdivieso S; Duval F; Mokrani MC; Schaltenbrand N; Castro JO; Crocq MA; Macher JP
    Psychiatry Res; 1996 Feb; 60(1):23-32. PubMed ID: 8852865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP; Haskett RF; Albala AA; Carroll BJ; Lohr NE
    Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol secretion in endogenous depression. II. Time-related functions.
    Halbreich U; Asnis GM; Shindledecker R; Zumoff B; Nathan RS
    Arch Gen Psychiatry; 1985 Sep; 42(9):909-14. PubMed ID: 4037991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DST in bulimia without endogenous depression.
    Levy AB; Dixon KN
    Biol Psychiatry; 1987 Jun; 22(6):783-6. PubMed ID: 3593818
    [No Abstract]   [Full Text] [Related]  

  • 15. The hypothalamic-pituitary-adrenal system in panic disorder.
    Goldstein S; Halbreich U; Asnis G; Endicott J; Alvir J
    Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological markers in affective diseases].
    Klein HE
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1987; 45():1-164. PubMed ID: 3317007
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
    Jakovljević M; Mück-Seler D; Pivac N; Crncević Z
    Neuropsychobiology; 1998; 37(3):142-5. PubMed ID: 9597670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis.
    Kaneko M; Murata S; Hoshino Y; Takahagi K; Yokoyama F; Watanabe M; Kumashiro H
    Neuropsychobiology; 1990-1991; 24(1):12-6. PubMed ID: 2132636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test.
    Miller AH; Spencer RL; Pulera M; Kang S; McEwen BS; Stein M
    Biol Psychiatry; 1992 Nov; 32(10):850-69. PubMed ID: 1334712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.